0002068421-25-000001.txt : 20250515 0002068421-25-000001.hdr.sgml : 20250515 20250515140159 ACCESSION NUMBER: 0002068421-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250515 DATE AS OF CHANGE: 20250515 EFFECTIVENESS DATE: 20250515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Shenandoah Therapeutics Inc. CENTRAL INDEX KEY: 0002068421 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-546256 FILM NUMBER: 25951299 BUSINESS ADDRESS: STREET 1: 329 OYSTER POINT BLVD. STREET 2: 3RD FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-239-0503 MAIL ADDRESS: STREET 1: 329 OYSTER POINT BLVD. STREET 2: 3RD FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0708 D LIVE 0002068421 Shenandoah Therapeutics Inc. 329 OYSTER POINT BLVD. 3RD FLOOR SOUTH SAN FRANCISCO CA CALIFORNIA 94080 650-239-0503 DELAWARE None None Corporation true 2022 Isabella Graef c/o Shenandoah Therapeutics Inc. 329 Oyster Point Blvd., 3rd Floor South San Francisco CA CALIFORNIA 94080 Executive Officer Director Mark Stepka c/o Shenandoah Therapeutics Inc. 329 Oyster Point Blvd., 3rd Floor South San Francisco CA CALIFORNIA 94080 Executive Officer Jim Edwards c/o Shenandoah Therapeutics Inc. 329 Oyster Point Blvd., 3rd Floor South San Francisco CA CALIFORNIA 94080 Director Gary Yeung c/o Shenandoah Therapeutics Inc. 329 Oyster Point Blvd., 3rd Floor South San Francisco CA CALIFORNIA 94080 Director Wendy Young c/o Shenandoah Therapeutics Inc. 329 Oyster Point Blvd., 3rd Floor South San Francisco CA CALIFORNIA 94080 Director Nathanael Gray c/o Shenandoah Therapeutics Inc. 329 Oyster Point Blvd., 3rd Floor South San Francisco CA CALIFORNIA 94080 Director Other Technology Decline to Disclose 06b false 2025-05-02 false true false 0 21499989 21499989 0 false 12 0 0 0 false Shenandoah Therapeutics Inc. Mark Stepka /s/ Mark Stepka Chief Financial Officer 2025-05-14